Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
Reapplix
Reapplix
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
Reapplix
Total Funding
$1.7 M
Reapplix Summary
Company Summary
Overview
Reapplix is a biotech company that specializes in the biological treatment and management of diabetic foot ulcers. It develops 3C Patch System that identifies blood-derived proteins that improve wound healing.
Type
Private
Status
Active
Founded
2008
HQ
Birkerød, DK
|
view all locations
Website
https://reapplix.com/
Cybersecurity rating
Sectors
Healthcare
biotech
diabetes
healthtech
medical devices
Homepage
Linkedin
Table of Contents
Key People
Locations
Competitors
Key People
Ulrik Spork,
Chairman
Rasmus Lundquist,
Chief Scientific Officer
Morten Have Rasmussen,
Chief Financial Officer
Niels Holm,
COO
and 8 others
Locations
View all
2 locations detected
Birkerød
HQ
Denmark
Blokken 45
Southlake, TX
United States
325 Miron Dr #140
Competitors and Similar Companies
Kaleido
Healthcare - Private
Intuity Medical
Healthcare - Private
Bluedrop Medical
Healthcare - Private
NitricGen
Healthcare - Private
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top